A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing ...
Randomized, blinded clinical study evaluating injectable autologous hair follicle secretome in patients with androgenic ...
Racial disparities on incidence and survival in Kaposi sarcoma during the post-retroviral era: A Surveillance, Epidemiology and End Results program database (2000-2021) retrospective analysis. This is ...
Anthropic research shows developers using AI assistance scored 17% lower on comprehension tests when learning new coding ...
When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...
Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...
‘A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial’ by David Erritzoe et al. was published in Nature Medicine at 16:00 UK time on ...
GRAIL's topline results from the NHS-Galleri trial were a clear disappointment with no major implications on ...